Patents by Inventor Christiaan M. Saris

Christiaan M. Saris has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Fibroblast Growth Factor Receptor-Like Molecules and Uses Thereof
    Publication number: 20140273089
    Abstract: The present invention provides Fibroblast Growth Factor Receptor-Like (FGFR-L) polypeptides and nucleic acid molecules encoding the same. The invention also provides selective binding agents, vectors, host cells, and methods for producing FGFR-L polypeptides. The inventio further provides pharmaceutical compositions and methods for the diagnosis, treatment, amelioration, and/or prevention of diseases, disorders, and conditions associated with FGFR-L polypeptides.
    Type: Application
    Filed: March 14, 2013
    Publication date: September 18, 2014
    Applicant: AMGEN, INC.
    Inventors: Christiaan M. Saris, Sharon X. Mu, Min Xia, Thomas Charles Boone, Todd Covey
  • Antibodies to thymic stromal lymphopoietin (TSLP) receptor molecules and uses thereof
    Patent number: 8344110
    Abstract: The present invention provides Thymic Stromal Lymphopoietin Receptor (TSLPR) polypeptides and nucleic acid molecules encoding the same. The invention also provides selective binding agents, vectors, host cells, and methods for producing TSLPR polypeptides. The invention further provides pharmaceutical compositions and methods for the diagnosis, treatment, amelioration, and/or prevention of diseases, disorders, and conditions associated with TSLPR polypeptides.
    Type: Grant
    Filed: June 8, 2011
    Date of Patent: January 1, 2013
    Assignee: Amgen Inc.
    Inventors: Christiaan M Saris, Ming-Shi Chang
  • ANTIBODIES TO THYMIC STROMAL LYMPHOPOIETIN RECEPTOR MOLECULES AND USES THEREOF
    Publication number: 20110305705
    Abstract: The present invention provides Thymic Stromal Lymphopoietin Receptor (TSLPR) polypeptides and nucleic acid molecules encoding the same. The invention also provides selective binding agents, vectors, host cells, and methods for producing TSLPR polypeptides. The invention further provides pharmaceutical compositions and methods for the diagnosis, treatment, amelioration, and/or prevention of diseases, disorders, and conditions associated with TSLPR polypeptides.
    Type: Application
    Filed: June 8, 2011
    Publication date: December 15, 2011
    Applicant: AMGEN INC.
    Inventors: Christiaan M. Saris, Ming-Shi Chang
  • Nucleic acid molecules encoding thymic stromal lympopoietin receptor proteins and a process for producing the encoded polypeptides thereof
    Patent number: 7964713
    Abstract: The present invention provides Thymic Stromal Lymphopoietin Receptor (TSLPR) polypeptides and nucleic acid molecules encoding the same. The invention also provides selective binding agents, vectors, host cells, and methods for producing TSLPR polypeptides. The invention further provides pharmaceutical compositions and methods for the diagnosis, treatment, amelioration, and/or prevention of diseases, disorders, and conditions associated with TSLPR polypeptides.
    Type: Grant
    Filed: June 28, 2001
    Date of Patent: June 21, 2011
    Assignee: Amgen Inc.
    Inventors: Christiaan M. Saris, Ming-Shi Chang
  • Nucleic acids encoding fibroblast growth factor receptor-like proteins and uses thereof
    Patent number: 7348162
    Abstract: The present invention provides Fibroblast Growth Factor Receptor-Like (FGFR-L) polypeptides and nucleic acid molecules encoding the same. The invention also provides selective binding agents, vectors, host cells, and methods for producing FGFR-L polypeptides. The invention further provides pharmaceutical compositions and methods for the diagnosis, treatment, amelioration, and/or prevention of diseases, disorders, and conditions associated with FGFR-L polypeptides.
    Type: Grant
    Filed: March 22, 2001
    Date of Patent: March 25, 2008
    Assignee: Amgen Inc.
    Inventors: Christiaan M. Saris, Sharon X. Mu, Min Xia, Thomas Charles Boone, Todd Covey
  • Fibroblast growth factor receptor-like molecules and uses thereof
    Publication number: 20030087384
    Abstract: The present invention provides Fibroblast Growth Factor Receptor-Like (FGFR-L) polypeptides and nucleic acid molecules encoding the same. The invention also provides selective binding agents, vectors, host cells, and methods for producing FGFR-L polypeptides. The invention further provides pharmaceutical compositions and methods for the diagnosis, treatment, amelioration, and/or prevention of diseases, disorders, and conditions associated with FGFR-L polypeptides.
    Type: Application
    Filed: August 28, 2002
    Publication date: May 8, 2003
    Applicant: Amgen Inc. A Corporation of the State of Delaware
    Inventors: Christiaan M. Saris, Sharon X. Mu, Min Xia, Thomas Charles Boone, Todd Covey
  • Interleukin-1 receptor antagonist-related molecules and uses thereof
    Publication number: 20030004106
    Abstract: The present invention provides novel Interleukin-1 Receptor Antagonist-Related (IL-1ra-R) polypeptides and nucleic acid molecules encoding the same. The invention also provides selective binding agents, vectors, host cells, and methods for producing IL-1ra-R polypeptides. The invention further provides pharmaceutical compositions and methods for the diagnosis, treatment, amelioration, and/or prevention of diseases, disorders, and conditions associated with IL-1ra-R polypeptides.
    Type: Application
    Filed: May 6, 2002
    Publication date: January 2, 2003
    Applicant: Amgen, Inc., A Corporation of the State of Delaware
    Inventors: Christiaan M. Saris, Jennifer Giles, Sharon X. Mu, Min Xia, Michael Brian Bass, Roger Craveiro
  • Thymic stromal lymphopoietin receptor molecules and uses thereof
    Publication number: 20020068323
    Abstract: The present invention provides Thymic Stromal Lymphopoietin Receptor (TSLPR) polypeptides and nucleic acid molecules encoding the same. The invention also provides selective binding agents, vectors, host cells, and methods for producing TSLPR polypeptides. The invention further provides pharmaceutical compositions and methods for the diagnosis, treatment, amelioration, and/or prevention of diseases, disorders, and conditions associated with TSLPR polypeptides.
    Type: Application
    Filed: June 28, 2001
    Publication date: June 6, 2002
    Applicant: Amgen, Inc.
    Inventors: Christiaan M. Saris, Ming-Shi Chang
  • Fibroblast growth factor receptor-like molecules and uses thereof
    Publication number: 20020009776
    Abstract: The present invention provides Fibroblast Growth Factor Receptor-Like (FGFR-L) polypeptides and nucleic acid molecules encoding the same. The invention also provides selective binding agents, vectors, host cells, and methods for producing FGFR-L polypeptides. The invention further provides pharmaceutical compositions and methods for the diagnosis, treatment, amelioration, and/or prevention of diseases, disorders, and conditions associated with FGFR-L polypeptides.
    Type: Application
    Filed: March 22, 2001
    Publication date: January 24, 2002
    Applicant: Amgen, Inc.
    Inventors: Christiaan M. Saris, Sharon X. Mu, Min Xia, Thomas Charles Boone, Todd Covey